Ainos Q2 FY26 net loss widens 12% to $4.59 million

• Ainos posted a Q2 net loss of USD 4.59 million, widening 12% from a year earlier as operating loss grew 17% to USD 4.4 million.
• Revenue sank 97% to USD 152, with R&D edging down 3% to USD 1.85 million while SG&A jumped 39% to USD 2.55 million.
• For H1, net loss narrowed 4% to USD 7.05 million as operating loss improved 3% to USD 6.68 million.
• H1 revenue fell 100% to USD 313, reflecting no revenue from AI Nose-related programs versus pet supplement revenue of USD 313.
• Cash rose to USD 1.42 million at June 30, 2026 from USD 417,353 at Dec. 31, 2025, supported by USD 3.41 million in financing cash flow.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ainos Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035833), on August 03, 2026, and is solely responsible for the information contained therein.